@inproceedings{inproceedings, title  = {{Early changes in patient-relevant endpoints in three tralokinumab pivotal phase III trials (ECZTRA 1-3) in adult patients with moderate-to-severe atopic dermatitis}},

 url = {{}},

 year = {{2021}},

 month = {{1}},

 author = {{Silverberg JI and Cork M and Wollenberg A and Katoh N and Steffensen LA and Kurbasic A and Olsen CK and Kuznetsova A and Osterdal ML and Vilsboll AW and Deleuran M et al}},

 volume = {{184}},

 journal = {{BRITISH JOURNAL OF DERMATOLOGY}},

 issue = {{3}},

 pages = {{E64-E64}},

 note = {{Accessed on 2024/12/22}}}